P533: SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA DEMETHYLATION AGENT + CAG REGIMEN IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA: INTERIM ANALYSIS

• X.-N. Gao,
• Y.-F. Su,
• Y. Jing,
• J. Wang,
• L. Xu,
• L.-L. Zhang,
• A. Wang,
• Y.-Z. Wang,
• Y.-F. Li,
• D.-H. Liu

Affiliations

X.-N. Gao

1 Senior Department of Hematology, the Fifth Medical Center

Y.-F. Su

1 Senior Department of Hematology, the Fifth Medical Center

Y. Jing

2 Department of Hematology, the First Medical Center, Chinese PLA General Hospital, Beijing, China

J. Wang

1 Senior Department of Hematology, the Fifth Medical Center

L. Xu

1 Senior Department of Hematology, the Fifth Medical Center

L.-L. Zhang

2 Department of Hematology, the First Medical Center, Chinese PLA General Hospital, Beijing, China

A. Wang

1 Senior Department of Hematology, the Fifth Medical Center

Y.-Z. Wang

1 Senior Department of Hematology, the Fifth Medical Center

Y.-F. Li

2 Department of Hematology, the First Medical Center, Chinese PLA General Hospital, Beijing, China

D.-H. Liu

1 Senior Department of Hematology, the Fifth Medical Center